# Pediatric severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and Multisystem Inflammatory Syndrome in Children (MIS-C) long-term follow-up

> **NIH NIH N01** · LEIDOS BIOMEDICAL RESEARCH, INC. · 2021 · $18,781,641

## Abstract

This is a multisite prospective observational study to evaluate the clinical sequelae of symptomatic and asymptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in the pediatric population (aged 0-21 years), including coronavirus disease 2019 (COVID-19) and multisystem inflammatory syndrome in children (MIS-C).

## Key facts

- **NIH application ID:** 10506153
- **Project number:** 75N91019D00024-P00001-759102000039-2
- **Recipient organization:** LEIDOS BIOMEDICAL RESEARCH, INC.
- **Principal Investigator:** GINA MONTEALEGRE
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $18,781,641
- **Award type:** —
- **Project period:** 2020-09-02 → 2023-06-29

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10506153

## Citation

> US National Institutes of Health, RePORTER application 10506153, Pediatric severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and Multisystem Inflammatory Syndrome in Children (MIS-C) long-term follow-up (75N91019D00024-P00001-759102000039-2). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10506153. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*